PRDM16 and schizophrenia: Although our data suggest that PRDM16-DT is specifically decreased in the brains of AD patients while remaining unaffected in FTD and schizophrenia patients, we cannot exclude the possibility that PRDM16-DT is affected in other brain diseases.